The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome.
about
BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infectionBanff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts.BK virus nephropathy in renal transplant recipients.Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipientsFactors Influencing Graft Outcomes Following Diagnosis of Polyomavirus -Associated Nephropathy after Renal Transplantation.BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches.Impact of combined acute rejection on BK virus-associated nephropathy in kidney transplantation.Noninvasive prognostication of polyomavirus BK virus-associated nephropathy.Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation.BK virus infection: an update on diagnosis and treatment.Current problems in screening, diagnosis and treatment of polyomavirus BK nephropathy.IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation.Histological Evolution of BK Virus-Associated Nephropathy: Importance of Integrating Clinical and Pathological Findings.BK Virus Nephropathy: Histological Evolution by Sequential Pathology.Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.BK polyomavirus in solid organ transplantation.Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.Polyoma virus nephropathy in kidney transplantation.Banff Classification of Polyomavirus Nephropathy: A New Tool for Research and Clinical Practice.Prediction of Early BK Virus Infection in Kidney Transplant Recipients by the Number of Cells With Intranuclear Inclusion Bodies (Decoy Cells).Fluorodeoxyglucose F(18) Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft Rejection.Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients.
P2860
Q28070240-36D4995C-6FFF-4DE9-AC6A-986E30416BC0Q30371017-7C2D0C98-CBFF-458B-8E78-95FCC47AB441Q34509585-FCE92DE4-AB84-41C7-9C2B-D1B23D0BE593Q36126901-5773FF8B-4042-4314-B27E-8B1B2A1BDCDEQ36257694-88C24982-C9E5-4028-95FD-3064C2788245Q37375153-48540515-BB78-4853-B513-F4111FC69A04Q37378725-27C038A7-44B4-41F8-B5B5-1D6F939E0381Q37631149-F2A318B9-9C1F-463E-8D0B-7C2954E1D383Q38154130-FD88BC60-FE37-4798-9394-06DDBE0BA0D3Q38191554-6A343725-92E8-41E5-969D-359A01457AACQ38212983-15777E86-66D2-47B6-86BC-E860CFED9630Q38656414-26AE2065-9C74-4177-8DD1-30C7C50DBE5CQ40236939-8E7641E6-19D7-440C-8DAD-FF83699CE8DBQ40260844-490DA31C-364D-4DC1-BE99-D0941EA8B88AQ41192323-E22F50F7-D867-4E40-89FE-B3D7FF27BCCAQ42272314-62B594B7-48A9-472C-BFD5-75F759F551AFQ45326184-3B03E634-E069-4D7B-8F05-D003D25445D7Q47246603-FB17A082-75B3-4A75-93D6-94A348677048Q47556851-B7610CB8-C755-4B05-8676-ED109BA6ACCEQ49680610-30DECE44-EBEB-4FB6-B716-B864EF7A2D7DQ50081764-7EB82312-9E90-47C1-AAB7-ED76295DF54CQ52991425-4BC4C038-4EDB-4B58-8BA8-59319D8BB059Q55517127-22C9C05C-ED83-4B29-905D-FEAA87BE7488
P2860
The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The Banff 2009 Working Proposa ...... terminant of clinical outcome.
@ast
The Banff 2009 Working Proposa ...... terminant of clinical outcome.
@en
type
label
The Banff 2009 Working Proposa ...... terminant of clinical outcome.
@ast
The Banff 2009 Working Proposa ...... terminant of clinical outcome.
@en
prefLabel
The Banff 2009 Working Proposa ...... terminant of clinical outcome.
@ast
The Banff 2009 Working Proposa ...... terminant of clinical outcome.
@en
P2093
P2860
P1476
The Banff 2009 Working Proposa ...... terminant of clinical outcome.
@en
P2093
P2860
P304
P356
10.1111/J.1600-6143.2012.03993.X
P407
P577
2012-03-05T00:00:00Z